PHARMACEUTICAL APPROACHES OF IL-6 INHIBITORS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS, FOCUS ON NEW FDA APPROVED DRUG: SARILUMAB Journal title: World Journal of Pharmaceutical Research Authors: Reza Andriani Subject(s):